Vandegrift v. United States

13 Ct. Cust. 30, 1925 WL 29401, 1925 CCPA LEXIS 52
CourtCourt of Customs and Patent Appeals
DecidedApril 20, 1925
DocketNo. 2416
StatusPublished
Cited by19 cases

This text of 13 Ct. Cust. 30 (Vandegrift v. United States) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vandegrift v. United States, 13 Ct. Cust. 30, 1925 WL 29401, 1925 CCPA LEXIS 52 (ccpa 1925).

Opinion

Bland, Judge,

delivered the opinion of the court:

Certain ovarian and pituitary cattle glands and different organs of cattle imported from the Argentine, South America, by H. K. Mul-ford & Co., of Philadelphia, and used by them in the manufacture of solutions for hypodermic injection were classified under paragraph 34 of the act of September 21, 1922, at 10 per centum ad valorem as a drug of animal origin advanced in value or condition by grinding' Paragraph 34 is as follows:

Drugs, such as barks, beans, berries, buds, bulbs, bulbous roots, excrescences, fruits, flowers, dried fibers, dried insects, grains, herbs, leaves, lichens, mosses, roots, stems, vegetables, seeds (aromatic, not garden seeds), seeds of morbid growth, weeds, and all other drugs of vegetable or animal origin; any of the [31]*31foregoing which are natural and uncompounded drugs and not edible, and not specially provided for, but which are advanced in value or condition by shredding, grinding, chipping, crushing, or any other process or treatment whatever beyond that essential to the proper packing of the drugs and the prevention of decay or deterioration pending manufacture, 10 per centum ad valorem: Provided, That the term “drug” wherever used in this act shall include only those substances having therapeutic or medicinal properties and chiefly used for medicinal purposes: And provided further, That no article containing alcohol shall be classified for duty under this paragraph.

The importers protested, claiming them free of duty as crude drugs of animal origin, dried only for the purpose of transportation, under paragraph 1567 of said act, which is as follows:

Drugs, such as barks, beans,- berries, buds, bulbs, bulbous roots, excrescences, fruits, flowers, dried fibers, dried insects, grains, herbs, leaves, lichens, mosses, logs, roots, stems, vegetables, seeds (aromatic, not garden seeds), seeds of morbid growth, weeds, and all other drugs of vegetable or animal origin; all of the foregoing which are natural and uncompounded drugs and not edible, and not specially provided for, and are in a crude state, not advanced in value or condition by shredding, grinding, chipping, crushing, or any other process or treatment whatever beyond that essential to the proper packing of the drugs and the prevention of decay or deterioration pending manufacture: Provided, That no article containing alcohol shall be admitted free of duty under this paragraph.

The majority opinion of the Board of General Appraisers, by General Appraisers McClelland and Sullivan, overruled the protest and sustained the classification of the collector. General Appraiser Brown dissented, tailing the position that the protest should have been sustained and the merchandise held free of duty under paragraph 1567.

The record discloses that the glands and different organs in controversy were natural, uncompounded, nonedible drugs of animal origin. The proof shows that by process of extraction certain active principles desired by the drug manufacturers are taken from the fresh glands after one hour’s immersion by soaking and using extreme heat, and that the fresh gland, undried and unground, is the most desirable form of the merchandise for this purpose; that the only way the fresh glands can be transported from the Argentine is in cold storage, where the glands are frozen, and that they must be kept frozen after transportation until used. The testimony shows that refrigerating space can not be had when desired and that the only other practical method of transporting the crude drug containing the active principles desired, is by drying and grinding the glands and transporting the dried glands in the powdered form.

Only one witness testified before the board. He, for 12 years, had been a pharmacist with H. K. Mulford & Co., and had had charge of the manufacture of all importations similar to the one in question. He testified that the fresh or frozen gland was most desirable and the drying and grinding of it occasioned them 10 [32]*32times more work than, would be necessary if the fresh gland was used; that one hour’s soaking was sufficient for the fresh gland while it took 10 hours to soak the dried ground gland, and that, in soaking the dried ground gland, a gelatinous matter accumulated' not desired for medicinal purposes, the elimination of which occasioned the expenditure of a great amount of time and actual labor.

The testimony shows that 1 pound of the dried ground gland is worth as much, or contains as much of the desired principle, as 6 pounds of the frozen gland, which is, no doubt, due to the fact that, in the drying process, the greater portion of the bulk of the gland is eliminated as water. The witness testified that they had never been able to transport the dried gland except when preserved by the use of boric acid, but that the importation, when so preserved, showed signs of mold and was not satisfactorily preserved, and that the boric acid system was not a success; that it took out the more active principles. The testimony does not disclose why the grinding of the dried gland was essential to the preparation or preservation while being transported, but the testimony is clear and undisputed that the drying and grinding is only for the purpose of transportation and preservation pending manufacture. It may be assumed that the -grinding of the dried gland is a part of the process of further drying so as to prevent mold or deterioration. It seems clear that grinding would facilitate drying.

Evidently the majority opinion rested upon the belief that the dried gland would not be an advanced drug within the meaning of the paragraph, but that the grinding of the dried gland was a process which advanced it beyond that which was essential to the proper packing of the drug and the prevention of decay or deterioration pending manufacture.

The proof shows that if the gland was dried, before the manufacturer could extract the principles, it must be ground. If the whole dried gland could be satisfactorily preserved without grinding it would seem that the grinding process would be an advancement bringing the commodity within paragraph 34, but as this record appears before us the proof shows that the gland is not imported in its dried condition except ground, and that attempts to import the dried unground gland were unsuccessful. It is clear that the drying is not an advancement, and in the record before us we think it appears that the grinding is a part of the process of preparation essential to the prevention of decay or deterioration pending manufacture. It may be a fact that the gland as a whole can be dried and satisfactorily transported to this country in its whole dried condition. If the record so showed we would be inclined to hold that [33]*33tbe grinding would be an advancement taking it out of paragraph 1567, but in this record the contrary appears.

Since the board’s decision in the case at bar, it has passed upon the same merchandise in Parke, Davis & Co. v. United States, T. D. 40475, G. A. 8887. This decision has been cited by the appellants to support their contention in this case. The Government insists that the Parke-Davis case, supra, does not support the appellants’ contention, for the reason that in that case there was no grinding process.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

B. L. Lemke & Co. v. United States
39 Cust. Ct. 253 (U.S. Customs Court, 1957)
U. S. Vitamin Corp. v. United States
43 C.C.P.A. 44 (Customs and Patent Appeals, 1956)
Chemical Specialties Co. v. United States
34 Cust. Ct. 155 (U.S. Customs Court, 1955)
U. S. Vitamin Corp. v. United States
33 Cust. Ct. 269 (U.S. Customs Court, 1954)
Mackay Estate v. United States
28 Cust. Ct. 73 (U.S. Customs Court, 1952)
Thompson Hayward Chemical Co. v. United States
27 Cust. Ct. 69 (U.S. Customs Court, 1951)
Hebo v. United States
25 Cust. Ct. 93 (U.S. Customs Court, 1950)
Biological Raw Products Co. v. United States
25 Cust. Ct. 1 (U.S. Customs Court, 1950)
Ciba Pharmaceutical Products, Inc. v. United States
21 Cust. Ct. 156 (U.S. Customs Court, 1948)
United States v. Judson Sheldon Corp.
33 C.C.P.A. 73 (Customs and Patent Appeals, 1945)
Geo. S. Bush & Co. v. United States
15 Cust. Ct. 83 (U.S. Customs Court, 1945)
Sherka Chemical Co. v. United States
33 C.C.P.A. 53 (Customs and Patent Appeals, 1945)
Judson Sheldon Corp. v. United States
13 Cust. Ct. 65 (U.S. Customs Court, 1944)
Dixie Veneer Co. v. United States
11 Cust. Ct. 112 (U.S. Customs Court, 1943)
F. W. Myers & Co. v. United States
29 C.C.P.A. 30 (Customs and Patent Appeals, 1941)
F. W. Myers & Co. v. United States
4 Cust. Ct. 276 (U.S. Customs Court, 1940)
United States v. Half Moon Manufacturing & Trading Co.
24 C.C.P.A. 232 (Customs and Patent Appeals, 1936)
United States v. R. Hillier's Son Co.
16 Ct. Cust. 103 (Customs and Patent Appeals, 1928)

Cite This Page — Counsel Stack

Bluebook (online)
13 Ct. Cust. 30, 1925 WL 29401, 1925 CCPA LEXIS 52, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vandegrift-v-united-states-ccpa-1925.